vs
雅保（ALB）与德康医疗（DXCM）财务数据对比。点击上方公司名可切换其他公司
雅保的季度营收约是德康医疗的1.1倍（$1.4B vs $1.3B），德康医疗净利率更高（21.2% vs -29.0%，领先50.2%），德康医疗同比增速更快（21.6% vs 15.9%），过去两年德康医疗的营收复合增速更高（12.0% vs 2.4%）
雅保是全球知名的特种化学品企业，业务覆盖研发、生产与全球销售，下设锂、溴、催化剂三大板块。锂业务线供应碳酸锂、氢氧化锂、氯化锂等锂化合物及相关试剂，产品广泛应用于消费电子、电动汽车锂电池、高性能润滑脂、热塑性弹性体等领域。
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
ALB vs DXCM — 直观对比
营收规模更大
ALB
是对方的1.1倍
$1.3B
营收增速更快
DXCM
高出5.6%
15.9%
净利率更高
DXCM
高出50.2%
-29.0%
两年增速更快
DXCM
近两年复合增速
2.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.3B |
| 净利润 | $-414.2M | $267.3M |
| 毛利率 | 13.9% | 62.9% |
| 营业利润率 | -15.2% | 25.6% |
| 净利率 | -29.0% | 21.2% |
| 营收同比 | 15.9% | 21.6% |
| 净利润同比 | -650.1% | 153.6% |
| 每股收益（稀释后） | $-3.88 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALBDXCM
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.4B | $1.3B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.1B | $1.0B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.4B | $994.2M | ||
| Q2 24 | $1.4B | $1.0B |
净利润ALBDXCM
| Q1 26 | — | $267.3M | ||
| Q4 25 | $-414.2M | $267.3M | ||
| Q3 25 | $-160.7M | $283.8M | ||
| Q2 25 | $22.9M | $179.8M | ||
| Q1 25 | $41.3M | $105.4M | ||
| Q4 24 | $75.3M | $151.7M | ||
| Q3 24 | $-1.1B | $134.6M | ||
| Q2 24 | $-188.2M | $143.5M |
毛利率ALBDXCM
| Q1 26 | — | 62.9% | ||
| Q4 25 | 13.9% | 62.9% | ||
| Q3 25 | 9.0% | 60.5% | ||
| Q2 25 | 14.8% | 59.5% | ||
| Q1 25 | 14.5% | 56.9% | ||
| Q4 24 | 11.2% | 58.9% | ||
| Q3 24 | -7.7% | 59.7% | ||
| Q2 24 | -0.7% | 62.4% |
营业利润率ALBDXCM
| Q1 26 | — | 25.6% | ||
| Q4 25 | -15.2% | 25.6% | ||
| Q3 25 | -16.6% | 20.1% | ||
| Q2 25 | 3.6% | 18.4% | ||
| Q1 25 | 1.8% | 12.9% | ||
| Q4 24 | 0.4% | 17.0% | ||
| Q3 24 | -81.9% | 15.3% | ||
| Q2 24 | -34.4% | 15.7% |
净利率ALBDXCM
| Q1 26 | — | 21.2% | ||
| Q4 25 | -29.0% | 21.2% | ||
| Q3 25 | -12.3% | 23.5% | ||
| Q2 25 | 1.7% | 15.5% | ||
| Q1 25 | 3.8% | 10.2% | ||
| Q4 24 | 6.1% | 13.6% | ||
| Q3 24 | -78.9% | 13.5% | ||
| Q2 24 | -13.2% | 14.3% |
每股收益（稀释后）ALBDXCM
| Q1 26 | — | $0.67 | ||
| Q4 25 | $-3.88 | $0.67 | ||
| Q3 25 | $-1.72 | $0.70 | ||
| Q2 25 | $-0.16 | $0.45 | ||
| Q1 25 | $0.00 | $0.27 | ||
| Q4 24 | $0.29 | $0.37 | ||
| Q3 24 | $-9.45 | $0.34 | ||
| Q2 24 | $-1.96 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $917.7M |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $9.5B | $2.7B |
| 总资产 | $16.4B | $6.3B |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ALBDXCM
| Q1 26 | — | $917.7M | ||
| Q4 25 | — | $917.7M | ||
| Q3 25 | $1.9B | $1.8B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | $1.5B | $904.9M | ||
| Q4 24 | $1.2B | $606.1M | ||
| Q3 24 | $1.7B | $621.2M | ||
| Q2 24 | $1.8B | $939.2M |
总债务ALBDXCM
| Q1 26 | — | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.6B | — | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $3.5B | — | ||
| Q4 24 | $3.5B | — | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.5B | — |
股东权益ALBDXCM
| Q1 26 | — | $2.7B | ||
| Q4 25 | $9.5B | $2.7B | ||
| Q3 25 | $10.0B | $2.7B | ||
| Q2 25 | $10.2B | $2.6B | ||
| Q1 25 | $10.0B | $2.3B | ||
| Q4 24 | $10.0B | $2.1B | ||
| Q3 24 | $10.2B | $2.0B | ||
| Q2 24 | $11.2B | $2.4B |
总资产ALBDXCM
| Q1 26 | — | $6.3B | ||
| Q4 25 | $16.4B | $6.3B | ||
| Q3 25 | $17.1B | $7.5B | ||
| Q2 25 | $17.3B | $7.3B | ||
| Q1 25 | $17.0B | $6.8B | ||
| Q4 24 | $16.6B | $6.5B | ||
| Q3 24 | $17.5B | $6.4B | ||
| Q2 24 | $18.4B | $6.8B |
负债/权益比ALBDXCM
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $388.5M | — |
| 自由现金流经营现金流 - 资本支出 | $233.1M | — |
| 自由现金流率自由现金流/营收 | 16.3% | — |
| 资本支出强度资本支出/营收 | 10.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $692.5M | — |
8季度趋势，按日历期对齐
经营现金流ALBDXCM
| Q1 26 | — | — | ||
| Q4 25 | $388.5M | $294.0M | ||
| Q3 25 | $355.6M | $659.9M | ||
| Q2 25 | $-7.2M | $303.0M | ||
| Q1 25 | $545.4M | $183.8M | ||
| Q4 24 | $674.0K | $301.4M | ||
| Q3 24 | $240.5M | $199.5M | ||
| Q2 24 | $362.9M | $279.4M |
自由现金流ALBDXCM
| Q1 26 | — | — | ||
| Q4 25 | $233.1M | $192.1M | ||
| Q3 25 | $223.4M | $579.4M | ||
| Q2 25 | $-126.8M | $208.9M | ||
| Q1 25 | $362.8M | $96.8M | ||
| Q4 24 | $-355.1M | $176.8M | ||
| Q3 24 | $-62.6M | $88.3M | ||
| Q2 24 | $-84.7M | $213.3M |
自由现金流率ALBDXCM
| Q1 26 | — | — | ||
| Q4 25 | 16.3% | 15.3% | ||
| Q3 25 | 17.1% | 47.9% | ||
| Q2 25 | -9.5% | 18.1% | ||
| Q1 25 | 33.7% | 9.3% | ||
| Q4 24 | -28.8% | 15.9% | ||
| Q3 24 | -4.6% | 8.9% | ||
| Q2 24 | -5.9% | 21.2% |
资本支出强度ALBDXCM
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 8.1% | ||
| Q3 25 | 10.1% | 6.7% | ||
| Q2 25 | 9.0% | 8.1% | ||
| Q1 25 | 17.0% | 8.4% | ||
| Q4 24 | 28.9% | 11.2% | ||
| Q3 24 | 22.4% | 11.2% | ||
| Q2 24 | 31.3% | 6.6% |
现金转化率ALBDXCM
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 2.33× | ||
| Q2 25 | -0.31× | 1.69× | ||
| Q1 25 | 13.19× | 1.74× | ||
| Q4 24 | 0.01× | 1.99× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALB
| Energy Storage | $759.1M | 53% |
| Specialties | $348.9M | 24% |
| Ketjen | $320.1M | 22% |
DXCM
暂无分部数据
